The coexistence of hypercalcemia and hypoglycemia in a patient with a renal tumor and B cell lymphoma
SUMMARY Paraneoplastic syndromes are a heterogeneous group of malignant diseases caused by events which involve endocrine, immune and metabolic aspects and whose symptoms vary according to the substance produced and the primary tumor. Hypercalcemia is a frequent complication in cancer patients. Prognosis of cancer patients with hypercalcemia is usually poor. A factor called parathyroid hormone related peptide, whose actions are similar to those of the parathyroid hormone, is thought to be the most common cause of malignancy associated hypercalcemia. Non-islet hypoglycemic cell tumor consists of a rare syndrome characterized by the presence of a solid tumor and severe fasting hypoglycemia determined by an insulin-independent pathway. We report a case of a 59-year-old-man with a renal tumor and a T-cell rich large B cell lymphoma who was hospitalized due to severe hypercalcemia and hypoglycemia. The laboratory examination reported hypercalcemia with inhibited PTH and hypoglycemia with inhibited insulin secretion, arriving to the conclusion of tumoral peptide production. He received denosumab and corticoid therapy. The patient died one month later despite initial improvement after medical treatment. While a single paraneoplastic manifestation may be expected in most tumors, the coexistence of two or more of them is rare, except in hepatocellular carcinomas, and it has not yet been described in renal tumors.
Main Authors: | , , , , , |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Sociedade Brasileira de Endocrinologia e Metabologia
2017
|
Online Access: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972017000100098 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
oai:scielo:S2359-39972017000100098 |
---|---|
record_format |
ojs |
spelling |
oai:scielo:S2359-399720170001000982017-02-20The coexistence of hypercalcemia and hypoglycemia in a patient with a renal tumor and B cell lymphomaSoutelo,JimenaMoldes,SofíaFrisone,CieloSalvá,LauraAgostinis,CeciliaFaraj,GabrielSUMMARY Paraneoplastic syndromes are a heterogeneous group of malignant diseases caused by events which involve endocrine, immune and metabolic aspects and whose symptoms vary according to the substance produced and the primary tumor. Hypercalcemia is a frequent complication in cancer patients. Prognosis of cancer patients with hypercalcemia is usually poor. A factor called parathyroid hormone related peptide, whose actions are similar to those of the parathyroid hormone, is thought to be the most common cause of malignancy associated hypercalcemia. Non-islet hypoglycemic cell tumor consists of a rare syndrome characterized by the presence of a solid tumor and severe fasting hypoglycemia determined by an insulin-independent pathway. We report a case of a 59-year-old-man with a renal tumor and a T-cell rich large B cell lymphoma who was hospitalized due to severe hypercalcemia and hypoglycemia. The laboratory examination reported hypercalcemia with inhibited PTH and hypoglycemia with inhibited insulin secretion, arriving to the conclusion of tumoral peptide production. He received denosumab and corticoid therapy. The patient died one month later despite initial improvement after medical treatment. While a single paraneoplastic manifestation may be expected in most tumors, the coexistence of two or more of them is rare, except in hepatocellular carcinomas, and it has not yet been described in renal tumors.info:eu-repo/semantics/openAccessSociedade Brasileira de Endocrinologia e MetabologiaArchives of Endocrinology and Metabolism v.61 n.1 20172017-02-01info:eu-repo/semantics/reporttext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972017000100098en10.1590/2359-3997000000212 |
institution |
SCIELO |
collection |
OJS |
country |
Brasil |
countrycode |
BR |
component |
Revista |
access |
En linea |
databasecode |
rev-scielo-br |
tag |
revista |
region |
America del Sur |
libraryname |
SciELO |
language |
English |
format |
Digital |
author |
Soutelo,Jimena Moldes,Sofía Frisone,Cielo Salvá,Laura Agostinis,Cecilia Faraj,Gabriel |
spellingShingle |
Soutelo,Jimena Moldes,Sofía Frisone,Cielo Salvá,Laura Agostinis,Cecilia Faraj,Gabriel The coexistence of hypercalcemia and hypoglycemia in a patient with a renal tumor and B cell lymphoma |
author_facet |
Soutelo,Jimena Moldes,Sofía Frisone,Cielo Salvá,Laura Agostinis,Cecilia Faraj,Gabriel |
author_sort |
Soutelo,Jimena |
title |
The coexistence of hypercalcemia and hypoglycemia in a patient with a renal tumor and B cell lymphoma |
title_short |
The coexistence of hypercalcemia and hypoglycemia in a patient with a renal tumor and B cell lymphoma |
title_full |
The coexistence of hypercalcemia and hypoglycemia in a patient with a renal tumor and B cell lymphoma |
title_fullStr |
The coexistence of hypercalcemia and hypoglycemia in a patient with a renal tumor and B cell lymphoma |
title_full_unstemmed |
The coexistence of hypercalcemia and hypoglycemia in a patient with a renal tumor and B cell lymphoma |
title_sort |
coexistence of hypercalcemia and hypoglycemia in a patient with a renal tumor and b cell lymphoma |
description |
SUMMARY Paraneoplastic syndromes are a heterogeneous group of malignant diseases caused by events which involve endocrine, immune and metabolic aspects and whose symptoms vary according to the substance produced and the primary tumor. Hypercalcemia is a frequent complication in cancer patients. Prognosis of cancer patients with hypercalcemia is usually poor. A factor called parathyroid hormone related peptide, whose actions are similar to those of the parathyroid hormone, is thought to be the most common cause of malignancy associated hypercalcemia. Non-islet hypoglycemic cell tumor consists of a rare syndrome characterized by the presence of a solid tumor and severe fasting hypoglycemia determined by an insulin-independent pathway. We report a case of a 59-year-old-man with a renal tumor and a T-cell rich large B cell lymphoma who was hospitalized due to severe hypercalcemia and hypoglycemia. The laboratory examination reported hypercalcemia with inhibited PTH and hypoglycemia with inhibited insulin secretion, arriving to the conclusion of tumoral peptide production. He received denosumab and corticoid therapy. The patient died one month later despite initial improvement after medical treatment. While a single paraneoplastic manifestation may be expected in most tumors, the coexistence of two or more of them is rare, except in hepatocellular carcinomas, and it has not yet been described in renal tumors. |
publisher |
Sociedade Brasileira de Endocrinologia e Metabologia |
publishDate |
2017 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972017000100098 |
work_keys_str_mv |
AT soutelojimena thecoexistenceofhypercalcemiaandhypoglycemiainapatientwitharenaltumorandbcelllymphoma AT moldessofia thecoexistenceofhypercalcemiaandhypoglycemiainapatientwitharenaltumorandbcelllymphoma AT frisonecielo thecoexistenceofhypercalcemiaandhypoglycemiainapatientwitharenaltumorandbcelllymphoma AT salvalaura thecoexistenceofhypercalcemiaandhypoglycemiainapatientwitharenaltumorandbcelllymphoma AT agostiniscecilia thecoexistenceofhypercalcemiaandhypoglycemiainapatientwitharenaltumorandbcelllymphoma AT farajgabriel thecoexistenceofhypercalcemiaandhypoglycemiainapatientwitharenaltumorandbcelllymphoma AT soutelojimena coexistenceofhypercalcemiaandhypoglycemiainapatientwitharenaltumorandbcelllymphoma AT moldessofia coexistenceofhypercalcemiaandhypoglycemiainapatientwitharenaltumorandbcelllymphoma AT frisonecielo coexistenceofhypercalcemiaandhypoglycemiainapatientwitharenaltumorandbcelllymphoma AT salvalaura coexistenceofhypercalcemiaandhypoglycemiainapatientwitharenaltumorandbcelllymphoma AT agostiniscecilia coexistenceofhypercalcemiaandhypoglycemiainapatientwitharenaltumorandbcelllymphoma AT farajgabriel coexistenceofhypercalcemiaandhypoglycemiainapatientwitharenaltumorandbcelllymphoma |
_version_ |
1756441365766471680 |